<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR12">
 <label>12.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>O'Connor</surname>
    <given-names>OA</given-names>
   </name>
   <name>
    <surname>Horwitz</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Masszi</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Van Hoof</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Brown</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Doorduijn</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Hess</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Jurczak</surname>
    <given-names>W</given-names>
   </name>
   <name>
    <surname>Knoblauch</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Chawla</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Bhat</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Choi</surname>
    <given-names>MR</given-names>
   </name>
   <name>
    <surname>Walewski</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Savage</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Foss</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Allen</surname>
    <given-names>LF</given-names>
   </name>
   <name>
    <surname>Shustov</surname>
    <given-names>A</given-names>
   </name>
  </person-group>
  <article-title>Belinostat in patients with relapsed or refractory peripheral T-cell lymphoma: results of the pivotal phase II BELIEF (CLN-19) study</article-title>
  <source>J Clin Oncol</source>
  <year>2015</year>
  <volume>33</volume>
  <fpage>2492</fpage>
  <lpage>2499</lpage>
  <pub-id pub-id-type="doi">10.1200/JCO.2014.59.2782</pub-id>
  <pub-id pub-id-type="pmid">26101246</pub-id>
 </element-citation>
</ref>
